Flucelvax Quadrivalent
Payments companies reported to CMS as associated with Flucelvax Quadrivalent. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Flucelvax Quadrivalent, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Flucelvax Quadrivalent
These are the largest totals companies reported as associated with Flucelvax Quadrivalent. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Donald Middleton | Pittsburgh, PA | Internal Medicine | $14,100.00 |
| Gary Marshall | Louisville, KY | Pediatric Infectious Diseases | $8,700.00 |
| Todd Wolynn | Pittsburgh, PA | Pediatrics | $8,643.00 |
| Tamera Coyne-Beasley | Birmingham, AL | Pediatrics | $6,515.53 |
| Ruth Carrico | Chicago, IL | Family | $6,460.50 |
| Stephen Pelton | Boston, MA | Pediatric Infectious Diseases | $6,038.50 |
| Flor De Maria Munoz | Houston, TX | Pediatric Infectious Diseases | $4,216.00 |
| Eric Ball | Lake Forest, CA | Pediatrics | $3,239.51 |
| Anita Chandra Puri | Chicago, IL | Pediatrics | $3,216.00 |
| Paul Hunter | Madison, WI | Family Medicine | $3,200.00 |
Prescribed Flucelvax Quadrivalent?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.